PMC:7386875 / 1563-1841 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":124,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"Several antithrombotic drugs have been proposed as potential therapies to prevent COVID-19-associated thrombosis, including heparin, FXII inhibitors, fibrinolytic drugs, nafamostat, and dipyridamole, many of which also possess pleiotropic anti-inflammatory or antiviral effects."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":82,"end":90},"obj":"Disease"},{"id":"T27","span":{"begin":102,"end":112},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"}],"text":"Several antithrombotic drugs have been proposed as potential therapies to prevent COVID-19-associated thrombosis, including heparin, FXII inhibitors, fibrinolytic drugs, nafamostat, and dipyridamole, many of which also possess pleiotropic anti-inflammatory or antiviral effects."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":23,"end":28},"obj":"Chemical"},{"id":"T3","span":{"begin":124,"end":131},"obj":"Chemical"},{"id":"T4","span":{"begin":138,"end":148},"obj":"Chemical"},{"id":"T5","span":{"begin":163,"end":168},"obj":"Chemical"},{"id":"T6","span":{"begin":170,"end":180},"obj":"Chemical"},{"id":"T7","span":{"begin":186,"end":198},"obj":"Chemical"},{"id":"T8","span":{"begin":260,"end":269},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_135466"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_4653"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"Several antithrombotic drugs have been proposed as potential therapies to prevent COVID-19-associated thrombosis, including heparin, FXII inhibitors, fibrinolytic drugs, nafamostat, and dipyridamole, many of which also possess pleiotropic anti-inflammatory or antiviral effects."}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":0,"end":278},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Several antithrombotic drugs have been proposed as potential therapies to prevent COVID-19-associated thrombosis, including heparin, FXII inhibitors, fibrinolytic drugs, nafamostat, and dipyridamole, many of which also possess pleiotropic anti-inflammatory or antiviral effects."}

{"project":"LitCovid-PubTator","denotations":[{"id":"57","span":{"begin":124,"end":131},"obj":"Chemical"},{"id":"58","span":{"begin":170,"end":180},"obj":"Chemical"},{"id":"59","span":{"begin":186,"end":198},"obj":"Chemical"},{"id":"85","span":{"begin":82,"end":90},"obj":"Disease"},{"id":"86","span":{"begin":102,"end":112},"obj":"Disease"}],"attributes":[{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:D006493"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:C032855"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:D004176"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"MESH:C000657245"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"MESH:D013927"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Several antithrombotic drugs have been proposed as potential therapies to prevent COVID-19-associated thrombosis, including heparin, FXII inhibitors, fibrinolytic drugs, nafamostat, and dipyridamole, many of which also possess pleiotropic anti-inflammatory or antiviral effects."}